Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details)

v3.22.2.2
Stockholders’ Equity (Details) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Aug. 11, 2022
Aug. 09, 2022
Jun. 28, 2022
Sep. 27, 2022
Mar. 31, 2022
Mar. 18, 2022
Jan. 20, 2022
Jan. 18, 2022
May 31, 2020
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Sep. 12, 2022
Sep. 07, 2022
Stockholders’ Equity (Details) [Line Items]                            
Restricted stock units (in Shares)   107,998         107,998              
Common stock shares issued $ 69,444     $ 21,360 $ 12,196                  
Accounts payable $ 50,000     $ 16,875 $ 10,000                  
Fair value price per share (in Dollars per share) $ 0.72     $ 0.79 $ 0.82         $ 0.65        
Issued shares (in Shares)     277,778                      
Legal settlement           $ 75,000   $ 75,000            
Fair value     $ 200,000                      
Price per share (in Dollars per share)     $ 0.72                      
Common stock, share issued (in Shares)                   13,007,409   11,293,030 1,153,845 1,153,845
Fair value                   $ 750,000        
Net proceeds related to placement                   725,050 $ 525,000      
Stockholders’ equity description                 During May 2020, the Company received $515,000 of a committed $565,000 from the sale of 135,527 shares of common stock (at a price of $3.80 per share) and warrants to purchase 169,409 shares of common stock, at an exercise price of $4.00 per share. As of September 30, 2022, $415,000 worth of the shares and warrants have been issued.          
Equity financing                   125,000   $ 125,000    
Unrecognized expense                   $ 551,000   $ 1,000,000    
Common Stock [Member]                            
Stockholders’ Equity (Details) [Line Items]                            
Issued shares (in Shares)           71,758   71,758            
Minimum [Member]                            
Stockholders’ Equity (Details) [Line Items]                            
Unrecognized expenses to be recognized, term                   12 months        
Maximum [Member]                            
Stockholders’ Equity (Details) [Line Items]                            
Unrecognized expenses to be recognized, term                   3 years        
Series A Convertible Preferred Stock [Member]                            
Stockholders’ Equity (Details) [Line Items]                            
Common shares (in Shares)                   45,000,000        
Convertible preferred shares authorized (in Shares)                   900,000        
Convertible preferred shares par value of per share (in Dollars per share)                   $ 0.001